Cargando…
Rosiglitazone activation of PPARγ suppresses fractalkine signaling
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is a key transcriptional regulator of both lipid metabolism and inflammation. The importance of PPARγ is accentuated by the widespread use of synthetic PPARγ agonists, thiazolidinediones (such as rosiglitazone), as drugs for i...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Society for Endocrinology
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805405/ https://www.ncbi.nlm.nih.gov/pubmed/19850645 http://dx.doi.org/10.1677/JME-09-0090 |